During this discussion, a KOL from the US East Coast offers valuable insights on the GOLD guidelines, patient segmentation, and inhaler prescribing habits and market shares. The conversation also includes an in-depth examination of biologics and patient eligibility. At the conclusion of the interview, the KOL expresses their views on unmet needs regarding clinical trial design and the management of asthma-COPD overlap syndrome. 

This interview was conducted on 28 May 2024. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal. 

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.